Description
Why It’s Done:
This combined test panel is used to:
• Diagnose active tuberculosis or NTM infections, especially in cases where clinical symptoms suggest infection, but traditional methods (e.g., AFB smear) fail to provide clear results.
• Provide early and accurate detection of mycobacteria to enable prompt treatment and reduce transmission, particularly in individuals at higher risk (e.g., immunocompromised patients).
• Differentiate between pulmonary and extrapulmonary TB or between TB and other respiratory diseases.
• Monitor treatment progress and check for recurrence or relapse, particularly in drug-resistant TB cases.
• Assist in identifying species and help guide appropriate treatment decisions.
Preparation:
• No special fasting or preparation is typically required.
• A sample collection is needed, depending on the site of infection:
o Sputum (for lung infections)
o Tissue biopsies, body fluids, or lymph node aspirates (for extrapulmonary infections)
• The sample should be collected in a sterile container and sent to the lab promptly to prevent contamination.
• Inform the healthcare provider if you have recently started TB treatment or have been exposed to individuals with tuberculosis.


